Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • HiSeq2000

    Hello everybody,

    since the new HiSeq2000 device is out now i was wondering whether anyone does already have some first hand experience and could comment on the performance/reliability of the machine. Could it recommendable to wait before investing into sequencing with this platform?

    Thanks in advance!

  • #2
    I don't have first experience... Maybe someone at the Broad institute will soon be able to comment, since they just purchased 51!

    Comment


    • #3
      We have our first HiSeq here at IGS but it will take 2-3 weeks before we will have production data. For now there will be some testing runs.

      What I do know is, the final output is a BCL file from two flow cells, binary equivalent of qseq which can be converted back to qseq using a Illumina supplied converter. The downstream analysis from that point is same as of GA.

      Hope this helps!
      -Abhi

      Comment


      • #4
        Originally posted by apratap View Post
        We have our first HiSeq here at IGS but it will take 2-3 weeks before we will have production data. For now there will be some testing runs.

        What I do know is, the final output is a BCL file from two flow cells, binary equivalent of qseq which can be converted back to qseq using a Illumina supplied converter. The downstream analysis from that point is same as of GA.

        Hope this helps!
        -Abhi
        Abhi, Could you comment on whether the HiSeq uses the same amount of reagents per run as a GAIIx or 2x as much since it is running 2 flow cells in parallel?

        Comment


        • #5
          I think it uses the same amount, just that one can load much more at the beginning, so it does not need to be topped off in between the run
          --
          bioinfosm

          Comment


          • #6
            Originally posted by bioinfosm View Post
            I think it uses the same amount, just that one can load much more at the beginning, so it does not need to be topped off in between the run
            Thanks for your reply, but I am a bit confused- what do you mean by topped off in between runs? Also, do you mean that each individual flow cell on the HiSeq uses the same amount of reagents as a single flow cell on the GAIIx, or that both together use the same amount as a single GAIIx flow cell (so effectively half the amount of reagents per flow cell)?

            Comment


            • #7
              right now the GAII's are running more often than the HiSeq. $$$ and we are having what looks like a weird reagent issue. Not to say it is reagent based yet, but straaange.

              Comment


              • #8
                The GAIIx and HiSeq use essentially the same amount of reagent per flowcell. However the HiSeq can run two flowcells at once and each flowcell generates 3-5x as much data.

                The word 'run' does not actually tell you very much about what someone is doing. It has always been a bit of an issue when comparing SOLiD to GA as one had two slide where the other used one flowcell.

                I find it much easier to describe the run in terms of it being single or paried end and by stipulating how many bases are being sequenced per read; e.g. SE36, PE72, etc. This would always refer to a single slide/flowcell.

                Comment


                • #9
                  Originally posted by greigite View Post
                  Thanks for your reply, but I am a bit confused- what do you mean by topped off in between runs? Also, do you mean that each individual flow cell on the HiSeq uses the same amount of reagents as a single flow cell on the GAIIx, or that both together use the same amount as a single GAIIx flow cell (so effectively half the amount of reagents per flow cell)?
                  Sorry I did not check back earlier.

                  James might have already answered you. I will be at a webinar on hiSEQ next week and will add any updates here
                  --
                  bioinfosm

                  Comment


                  • #10
                    Can anybody with a HiSeq comment on their computational resources downstream?

                    I see the site prep guide, do you have systems like this?

                    Comment


                    • #11
                      Hi mgogol

                      As far as the propriety pipeline of Illumina are concerned they remain to be same but in our experience,we have seen significant increase in the processing times as the raw data goes up 4-5x / lane on HiSeq. If you are thinking about buying IT infrastructure I would definitely consider having 1-2 machines with quad cores with > 64GB Ram if possible. Although 32 gb is feasible but as the cluster density on the HiSeq flowcell goes up chances are you will need more ram.

                      Hope this helps,
                      -Abhi

                      Comment


                      • #12
                        Thanks, that's helpful.

                        Comment


                        • #13
                          Originally posted by apratap View Post
                          Hi mgogol

                          As far as the propriety pipeline of Illumina are concerned they remain to be same but in our experience,we have seen significant increase in the processing times as the raw data goes up 4-5x / lane on HiSeq. If you are thinking about buying IT infrastructure I would definitely consider having 1-2 machines with quad cores with > 64GB Ram if possible. Although 32 gb is feasible but as the cluster density on the HiSeq flowcell goes up chances are you will need more ram.

                          Hope this helps,
                          -Abhi
                          We've seen a similarly huge increase in the processing times. My personal experience: aligning ~180-200 million 2x100PE whole-genome low coverage data reads from single lanes with BWA from *_sequence.txt files gives align (bwa aln and sampe) times in the 16-20 hour range per lane on 8 processors, not including downstream analysis.

                          Comment


                          • #14
                            200 million reads per lane? Is that the standard or are you pushing the limit? What is the standard # of reads/lane for a HiSeq?
                            Is the RTA of the HiSeq the same as GAII? In a GAII run the low-quality ends of reads are flagged with a quality score of 2 (ASCII B). Does the HiSeq RTA also output reads in this manner? What % of reads in the first and second run of a pair are low quality (QV=2)?
                            Is it comparable to GAII (<15% in first run, up to 40% in second run).

                            Comment


                            • #15
                              We "routinely" generate 70.000.000 passed filter sequences per lane on our HiSeq2000.

                              Comment

                              Latest Articles

                              Collapse

                              • seqadmin
                                Advanced Tools Transforming the Field of Cytogenomics
                                by seqadmin


                                At the intersection of cytogenetics and genomics lies the exciting field of cytogenomics. It focuses on studying chromosomes at a molecular scale, involving techniques that analyze either the whole genome or particular DNA sequences to examine variations in structure and behavior at the chromosomal or subchromosomal level. By integrating cytogenetic techniques with genomic analysis, researchers can effectively investigate chromosomal abnormalities related to diseases, particularly...
                                09-26-2023, 06:26 AM
                              • seqadmin
                                How RNA-Seq is Transforming Cancer Studies
                                by seqadmin



                                Cancer research has been transformed through numerous molecular techniques, with RNA sequencing (RNA-seq) playing a crucial role in understanding the complexity of the disease. Maša Ivin, Ph.D., Scientific Writer at Lexogen, and Yvonne Goepel Ph.D., Product Manager at Lexogen, remarked that “The high-throughput nature of RNA-seq allows for rapid profiling and deep exploration of the transcriptome.” They emphasized its indispensable role in cancer research, aiding in biomarker...
                                09-07-2023, 11:15 PM

                              ad_right_rmr

                              Collapse

                              News

                              Collapse

                              Topics Statistics Last Post
                              Started by seqadmin, Yesterday, 07:14 AM
                              0 responses
                              11 views
                              0 likes
                              Last Post seqadmin  
                              Started by seqadmin, 09-29-2023, 09:38 AM
                              0 responses
                              13 views
                              0 likes
                              Last Post seqadmin  
                              Started by seqadmin, 09-27-2023, 06:57 AM
                              0 responses
                              14 views
                              0 likes
                              Last Post seqadmin  
                              Started by seqadmin, 09-26-2023, 07:53 AM
                              0 responses
                              33 views
                              0 likes
                              Last Post seqadmin  
                              Working...
                              X